Conditional sentence

Global Heparin Market Report 2023: Sector is Expected to Reach $12.8 Billion by 2031 at a CAGR of 4.4% - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 1, 2023
Health, Pharmaceutical, Dialysis, UFH, Tissue, Deep vein thrombosis, The Writing on the Wall, Conditional sentence, DVT, Ageing, Heparin, LMWH, Research, Prevalence, USD, Pulmonary embolism, Pharmaceutical industry

The "Global Heparin Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Heparin Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.
  • The global heparin market value in 2022 was USD 8.70 billion, driven by the ongoing research and development in heparin-based therapies the globe.
  • The market size is anticipated to grow at a CAGR of 4.4% during the forecast period of 2023-2031 to achieve a value of USD 12.80 billion by 2031.
  • The heparin market is segmented into two main types: unfractionated heparin (UFH) and low molecular weight heparin (LMWH).

Global IV Tubing Sets and Accessories Market Report 2023: Increasing Number of Surgical Procedures Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 1, 2023
Medical Devices, Health, Infection, Infiltration, Conditional sentence, Injury, Growth, Cancer, IV, Prevalence, Diabetes, Patient, Phlebitis, Medical device

The global market for IV tubing sets and accessories has been witnessing a steady growth, propelled by several factors including the rising prevalence of chronic diseases, the increasing number of surgical procedures, and the advancements in technology

Key Points: 
  • The global market for IV tubing sets and accessories has been witnessing a steady growth, propelled by several factors including the rising prevalence of chronic diseases, the increasing number of surgical procedures, and the advancements in technology
    Chronic conditions like cancer, diabetes, and heart disease often require regular administration of medications and fluids, driving the demand for IV tubing sets and accessories.
  • Additionally, surgical procedures often involve the use of IV sets for anaesthesia administration, fluid replacement, and post-operative medication delivery, further contributing to the market's expansion
    The market is also being shaped by technological innovations.
  • For instance, the development of safety IV sets, which are designed to minimize needlestick injuries and infection risks, has led to increased adoption of these products.
  • Furthermore, the need for skilled healthcare professionals to manage IV therapy can limit the growth of the market in regions with a shortage of trained staff

Found Adds Healthcare Luminary Dr. Kyu Rhee to Medical Advisory Board

Retrieved on: 
Thursday, June 1, 2023
Mental Health, Health, Diabetes, Telemedicine, Virtual Medicine, Fitness & Nutrition, General Health, Psychology, HRSA, IBM, Health Resources and Services Administration, Obesity, Senior, Aetna, MPP, Stroke, Cardiovascular disease, Cancer, Innovation, Bangladesh Technical Education Board, Rural Health Workforce and The Patient Protection and Affordable Care Act, Hypertension, MD, Physician, Risk, Protocol, Conditional sentence, National Health Service Corps, CVS Health, Bias, Smoking, NIH, Disease, Management, Medical device

Evidence-based weight care program Found today announced that Kyu Rhee , MD, MPP, former Aetna Chief Medical Officer at CVS Health , has joined its Medical Advisory Board.

Key Points: 
  • Evidence-based weight care program Found today announced that Kyu Rhee , MD, MPP, former Aetna Chief Medical Officer at CVS Health , has joined its Medical Advisory Board.
  • Dr. Rhee will work closely with Found’s Chief Medical Officer, Dr. Rekha Kumar , as well as the company’s current Medical Advisory Board members Dr. Judith Korner , Dr. Larry Cheskin , Dr. Shebani Sethi Dalai and Dr. Shawn Cole in strengthening Found’s position at the forefront of clinical obesity care.
  • Classified as a chronic disease almost a decade ago, obesity is the second leading cause of preventable death, after smoking.
  • We’re thrilled to welcome Dr. Rhee to our team and look forward to his guidance and collaboration.”

NOBCO Announces Relocation of 2023 Annual Economic Development Conference in Miami-Dade County, Florida in Solidarity with NAACP's Travel Advisory

Retrieved on: 
Thursday, June 1, 2023
Conditional sentence, Left–right political spectrum, Travel, Democracy, Annual, National Organization of Black Law Enforcement Executives, Black, Organization, Social justice, National Association of Counties, Diversity, Naco, Inclusion, National Association, Conference, CRT, NAACP, Legislation, Management

The conference will be moved to Charlotte - Mecklenburg County, North Carolina in mid-October of 2023.

Key Points: 
  • The conference will be moved to Charlotte - Mecklenburg County, North Carolina in mid-October of 2023.
  • "Moving the NOBCO conference out of Florida is a difficult decision, but it is one that aligns with our core commitment to social justice.
  • We believe that by standing in solidarity with the NAACP we send a clear message that racial equality is non-negotiable.
  • NOBCO strongly condemns the passage of race-based laws by the Florida legislature and their subsequent signing into law by the governor.

'All United for MG' organises first-ever European Myasthenia Gravis Day on June 2nd leads to pan-European call for action supported by European leaders

Retrieved on: 
Thursday, June 1, 2023
AMIS, Evolis, United States corporate law, MBA, Doctor of Philosophy, MG, Patient, Frustration, Ageing, Health, Conditional sentence, Disease, Face, Policy, Health Economics, Weakness, Guilt, Leg, Approximation error, Sanders, SHE, MG3, Diagnosis, Rare, AMES, Caregiver, UOC, Employment, International, Depression, Eyelid, Neurology, Family, Arm, European Parliament, Anxiety, Quality of life, GP, Movement, Nursing, Pharmaceutical industry, Copper, Residential care, Myasthenia, F, MD, K, Let Us All Unite and Celebrate Together, EU, Myasthenia gravis, European, S, Qi

BRUSSELS, June 1, 2023 /PRNewswire/ -- The #AllUnitedforMG coalition, with the institutional support of argenx, brings together European patient associations and representatives from Belgium, France, Germany, Greece, Italy, Romania, Poland and Spain and aims to create awareness and gain recognition of this life-threatening disease, strengthen patients' rights for a better quality of life and obtain better patient care. The disease affects between 56.000 and 100.000 people in Europe 4.

Key Points: 
  • "Raising awareness about myasthenia gravis is not just about spreading knowledge, it's about empowering those who are living with it.
  • Our aim is to enhance patients' quality of life and reduce their mental burden," conclude the founders of the European Myasthenia Gravis Day.
  • "The first European Awareness Day for Myasthenia Gravis marks an important milestone towards increasing awareness and understanding of this rare disease.
  • Therefore we are very happy that there is finally a European Myasthenia Gravis Day to put a spotlight on this disease."

Remission Medical enters know-how agreement with Mayo Clinic to transform rheumatology care delivery

Retrieved on: 
Thursday, June 1, 2023
Medicine, ER, Mayo Clinic, Education, Urgent care center, EMR, PRO, Research, Multimedia, Patient, TTI, Patient-reported outcome, Triage, Practitioner, Algorithm, Rheumatoid arthritis, Rheumatology, Diagnosis, Health, Osteoarthritis, Gout, Lupus, Conditional sentence, Pharmaceutical industry, Nursing, Osteoporosis

RICHMOND, Va., June 1, 2023 /PRNewswire/ -- REMISSION MEDICAL today announced it has entered into a know-how agreement with Mayo Clinic to further develop Time to Treatment Initiation (TTI) in rheumatology and increase predictive patient care.

Key Points: 
  • RICHMOND, Va., June 1, 2023 /PRNewswire/ -- REMISSION MEDICAL today announced it has entered into a know-how agreement with Mayo Clinic to further develop Time to Treatment Initiation (TTI) in rheumatology and increase predictive patient care.
  • Mayo Clinic and Remission Medical announce collaboration in rheumatology.
  • Remission Medical is a virtual rheumatology clinic addressing the full range of rheumatological conditions including Rheumatoid Arthritis, Osteoporosis, Osteoarthritis, Lupus, and Gout, among others.
  • "Remission Medical's mission is to both improve access to care and improve the care overall for rheumatology patients across the spectrum from onset to – as our name implies – remission," said Blake Wehman, founder and CEO of Remission Medical.

'All United for MG' organises first-ever European Myasthenia Gravis Day on June 2nd leads to pan-European call for action supported by European leaders

Retrieved on: 
Thursday, June 1, 2023
AMIS, Evolis, United States corporate law, MBA, Doctor of Philosophy, MG, Patient, Frustration, Ageing, Health, Conditional sentence, Disease, Face, Policy, Health Economics, Weakness, Guilt, Leg, Approximation error, Sanders, SHE, MG3, Diagnosis, Rare, AMES, Caregiver, UOC, Employment, International, Depression, Eyelid, Neurology, Family, Arm, European Parliament, Anxiety, Quality of life, GP, Movement, Nursing, Pharmaceutical industry, Copper, Residential care, Myasthenia, F, MD, K, Let Us All Unite and Celebrate Together, EU, Myasthenia gravis, European, S, Qi

BRUSSELS, June 1, 2023 /PRNewswire/ -- The #AllUnitedforMG coalition, with the institutional support of argenx, brings together European patient associations and representatives from Belgium, France, Germany, Greece, Italy, Romania, Poland and Spain and aims to create awareness and gain recognition of this life-threatening disease, strengthen patients' rights for a better quality of life and obtain better patient care. The disease affects between 56.000 and 100.000 people in Europe 4.

Key Points: 
  • "Raising awareness about myasthenia gravis is not just about spreading knowledge, it's about empowering those who are living with it.
  • Our aim is to enhance patients' quality of life and reduce their mental burden," conclude the founders of the European Myasthenia Gravis Day.
  • "The first European Awareness Day for Myasthenia Gravis marks an important milestone towards increasing awareness and understanding of this rare disease.
  • Therefore we are very happy that there is finally a European Myasthenia Gravis Day to put a spotlight on this disease."

Ultrasonic Technology Market Report 2023 - Global Forecast Covering Market Size, Major Drivers, Trends And Top Segments, By The Business Research Company

Retrieved on: 
Thursday, June 1, 2023
Honeywell, Obstetrics, Prevalence, Electronics, 3D, Food safety, Omron, AG, Samsung, Olympus Corporation, Emerson Electric, 2D, General Electric Company, Algorithm, OLED, Siemens, Conditional sentence, Education minister, MEMS, Gynaecology, Artificial intelligence, Growth, Panasonic, Rockwell Automation, Robotics, Infineon Technologies, Medical imaging

LONDON, June 1, 2023 /PRNewswire/ -- As per The Business Research Company's Ultrasonic Technology Global Market Report 2023, the global ultrasonic technology market size will grow from $1.8 billion in 2022 to $2.1 billion in 2023 at a compound annual growth rate (CAGR) of 13%. The ultrasonic technology market size is then expected to grow to $3.3 billion in 2027 at a CAGR of 12%. Going forward, the increasing prevalence of chronic illness, rise in geriatric population, growth in the retail sector and the rising public concerns related to optimal food safety and quality will drive the ultrasonic technology market growth.

Key Points: 
  • LONDON, June 1, 2023 /PRNewswire/ -- As per The Business Research Company's Ultrasonic Technology Global Market Report 2023, the global ultrasonic technology market size will grow from $1.8 billion in 2022 to $2.1 billion in 2023 at a compound annual growth rate (CAGR) of 13%.
  • The global ultrasonic technology market is moderately fragmented, with a large number of small players in the market.
  • Major companies operating in the ultrasonic technology market are focusing on 3D ultrasound technology solutions to grow in the market.
  • As per the ultrasonic technology market analysis , Asia Pacific was the largest region in the ultrasonic technology market and was worth $718.2 million in 2022.

Ultrasonic Technology Market Report 2023 - Global Forecast Covering Market Size, Major Drivers, Trends And Top Segments, By The Business Research Company

Retrieved on: 
Thursday, June 1, 2023
Honeywell, Obstetrics, Prevalence, Electronics, 3D, Food safety, Omron, AG, Samsung, Olympus Corporation, Emerson Electric, 2D, General Electric Company, Algorithm, OLED, Siemens, Conditional sentence, Education minister, MEMS, Gynaecology, Artificial intelligence, Growth, Panasonic, Rockwell Automation, Robotics, Infineon Technologies, Medical imaging

LONDON, June 1, 2023 /PRNewswire/ -- As per The Business Research Company's Ultrasonic Technology Global Market Report 2023, the global ultrasonic technology market size will grow from $1.8 billion in 2022 to $2.1 billion in 2023 at a compound annual growth rate (CAGR) of 13%. The ultrasonic technology market size is then expected to grow to $3.3 billion in 2027 at a CAGR of 12%. Going forward, the increasing prevalence of chronic illness, rise in geriatric population, growth in the retail sector and the rising public concerns related to optimal food safety and quality will drive the ultrasonic technology market growth.

Key Points: 
  • LONDON, June 1, 2023 /PRNewswire/ -- As per The Business Research Company's Ultrasonic Technology Global Market Report 2023, the global ultrasonic technology market size will grow from $1.8 billion in 2022 to $2.1 billion in 2023 at a compound annual growth rate (CAGR) of 13%.
  • The global ultrasonic technology market is moderately fragmented, with a large number of small players in the market.
  • Major companies operating in the ultrasonic technology market are focusing on 3D ultrasound technology solutions to grow in the market.
  • As per the ultrasonic technology market analysis , Asia Pacific was the largest region in the ultrasonic technology market and was worth $718.2 million in 2022.

TCL's Latest Regional Market Launch Unveils New Mini LED QLED TVs and Smart Home Appliances Available in the Middle East and Africa

Retrieved on: 
Thursday, June 1, 2023
Atmos, Call, NFL, Call of Duty 2, Partnership, TCL, Club, LED-backlit LCD, Conditional sentence, Mini, Senior, QLED, Dolby Vision, MEA, VRR, HDR, Arsenal F.C., International League T20, Sport, Growth, Pakistan national cricket team, Dolby Atmos, Television, Cassette tape, Home appliance, Video game

DUBAI, UAE, June 1, 2023 /PRNewswire/ -- TCL, the world's TOP 2 TV brand and TOP 1 98-inch TV brand, today unveiled its latest multi-category products for the Middle East and Africa (MEA) market at an exclusive launch event in Dubai. TCL also announced its partnership with Arsenal Football Club as the Official Regional Consumer Electronics Partner of the Club, with the event being highlighted by a special appearance by Arsenal Legend, Robert Pires.

Key Points: 
  • The brand shared updates on Air Conditioners, with its innovative Gentle Cool series with its new sleek, minimalist, easy-to-clean design.
  • TCL also introduced its latest refrigerator and washing machine offerings to its consumers to help them live healthier and convenient lives.
  • Sunny Yang, General Manager of TCL MEA, said, "We are delighted to introduce TCL's latest generation of Mini LED and QLED TVs in the Middle East and Africa market.
  • We also look forward to showcasing our latest offerings in home appliances that will make lives easier."